Palvella Therapeutics, Inc
Ownership
Ownership Structure
Who owns Palvella Therapeutics, Inc (PVLA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 73.7% of the shares are freely tradable; institutional investors hold 96.4%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Suvretta Capital Management, LLC | 8.01 | 1,153,496 | +29.3 | 03/31/2026 |
| Bvf Inc | 6.67 | 960,989 | +9.3 | 03/31/2026 |
| Jennison Associates LLC | 6.67 | 960,619 | +50.0 | 06/30/2026 |
| Frazier Life Sciences Management, L.P. | 6.12 | 882,400 | +22.1 | 03/31/2026 |
| First Light Asset Management, LLC | 5.36 | 771,901 | -21.3 | 06/30/2026 |
| BlackRock Inc | 4.77 | 686,853 | +22.9 | 03/31/2026 |
| Frontier Capital Management CO Inc | 3.32 | 478,833 | +28.0 | 06/30/2026 |
| Vanguard Capital Management, LLC | 3.31 | 477,294 | +0.0 | 03/31/2026 |
| State Street Corp | 3.19 | 458,999 | +9.2 | 03/31/2026 |
| Federated Hermes Inc | 3.01 | 433,015 | +0.0 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Jenkins George M | Director | 160,116 | 24,705,899 $ | Sep 15, 2026 | direct |
| Kiritsy Christopher P | Director | 250 | 38,575 $ | Sep 2, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Jenkins George M | Director | Sell | 560 | 151.33 | 84,743 |
| Sep 15, 2026 | Jenkins George M | Director | Sell | 263 | 150.40 | 39,556 |
| Sep 15, 2026 | Jenkins George M | Director | Sell | 954 | 149.38 | 142,507 |
| Sep 14, 2026 | Jenkins George M | Director | Sell | 1,560 | 153.10 | 238,834 |
| Sep 14, 2026 | Jenkins George M | Director | Sell | 6,160 | 152.12 | 937,034 |
| Sep 14, 2026 | Jenkins George M | Director | Sell | 5,632 | 151.46 | 853,037 |
| Sep 11, 2026 | Jenkins George M | Director | Sell | 1,274 | 153.06 | 194,997 |
| Sep 11, 2026 | Jenkins George M | Director | Sell | 4,577 | 151.72 | 694,403 |
| Sep 11, 2026 | Jenkins George M | Director | Sell | 6,520 | 150.62 | 982,035 |
| Sep 2, 2026 | Kiritsy Christopher P | Director | Sell | 313 | 157.00 | 49,141 |
| Sep 2, 2026 | Kiritsy Christopher P | Director | Other | 313 | 127.20 | 39,814 |
| Aug 19, 2026 | Goin Kathleen | Chief Operating Officer | Sell | 302 | 156.77 | 47,345 |
| Aug 19, 2026 | Goin Kathleen | Chief Operating Officer | Sell | 102 | 155.59 | 15,870 |
| Aug 19, 2026 | Goin Kathleen | Chief Operating Officer | Sell | 400 | 153.00 | 61,199 |
| Aug 19, 2026 | Goin Kathleen | Chief Operating Officer | Sell | 1,998 | 151.80 | 303,292 |
| Aug 19, 2026 | Goin Kathleen | Chief Operating Officer | Sell | 1,500 | 151.39 | 227,085 |
| Aug 19, 2026 | Goin Kathleen | Chief Operating Officer | Other | 2,148 | 9.08 | 19,504 |
| Aug 19, 2026 | Goin Kathleen | Chief Operating Officer | Other | 2,154 | 7.14 | 15,380 |
| Jul 15, 2026 | Goin Kathleen | Chief Operating Officer | Sell | 1,911 | 150.25 | 287,133 |
| Jul 15, 2026 | Goin Kathleen | Chief Operating Officer | Sell | 1,029 | 149.27 | 153,595 |
| Jul 15, 2026 | Goin Kathleen | Chief Operating Officer | Sell | 840 | 148.40 | 124,658 |
| Jul 15, 2026 | Goin Kathleen | Chief Operating Officer | Sell | 522 | 147.14 | 76,805 |
| Jul 15, 2026 | Goin Kathleen | Chief Operating Officer | Other | 2,148 | 9.08 | 19,504 |
| Jul 15, 2026 | Goin Kathleen | Chief Operating Officer | Other | 2,154 | 7.14 | 15,380 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.